PET-CT vs Bone Scan — Which Finds Bone Spread Better?
Both scans can find bone metastases, but they detect different things. Which one your oncologist recommends depends on your cancer type and what clinical question needs answering — not on which scan is newer or more expensive.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026
- Two different questions — A bone scan shows where bone is reacting. PET-CT shows which lesions are metabolically active. Your oncologist chooses by what they need to know.
- Bone scan is not second-best — For prostate and breast cancer, a bone scan is the guideline-recommended first test — not a cheaper substitute for something better.
- PET-CT adds specific value — It is preferred when cancer tends to destroy bone directly, or when your oncologist needs to know whether treatment is working.
- Cost should not be your deciding factor — The right scan is the one that answers the clinical question. A more expensive test does not automatically give a more useful answer.
on Panel
Survival Rate*
Treated
(800+ reviews)
Both scans detect bone metastases, but they work differently. A bone scan shows bone repair activity and is the guideline-recommended starting point for most cancers. PET-CT shows metabolic activity and adds value when your oncologist needs to assess treatment response or find lytic spread. Your cancer type determines which is right, not cost alone.
CION offers PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.
How do a bone scan and PET-CT compare?
| Feature | Bone Scan | PET-CT (FDG) |
|---|---|---|
| How it works | Detects reactive bone formation using a radiotracer absorbed at sites of active bone repair | Detects metabolically active cells using a glucose-based tracer absorbed by cancer cells |
| Type of spread detected | Mainly osteoblastic (bone-forming) spread | Both osteoblastic and lytic (bone-destroying) spread |
| Soft tissue involvement | Not assessed | Assessed alongside bone in the same scan |
| Treatment response | Limited — cannot reliably distinguish active from healed lesions | Yes — shows whether a lesion is still metabolically active |
| Best cancer match | Prostate cancer initial staging; breast cancer protocols; most osteoblastic spread | Multiple myeloma; lytic spread; assessing response to treatment |
| Availability in India | Widely available at most major centres | Less widely available; specialist or partner imaging centre needed |
| Approximate cost (indicative, 2025) | Substantially lower | Significantly higher — often several times the cost of a bone scan |
What do these scan terms actually mean?
- Osteoblastic spread
- Bone metastases that trigger new bone formation around them. Prostate cancer most commonly causes this. A bone scan picks these lesions up reliably.
- Lytic spread
- Bone metastases that destroy bone directly without triggering much repair. Multiple myeloma and kidney cancer often cause this. Bone scans can miss purely lytic disease.
- FDG (fluorodeoxyglucose)
- The glucose-like radiotracer used in PET-CT. Cancer cells absorb more of it than normal tissue, which is how they appear as bright spots on the scan.
- Technetium-99m
- The radiotracer injected for a bone scan. It collects in areas of active bone repair — the sites where metastases typically trigger a response.
- Metabolic activity
- How much energy a cell is consuming. PET-CT measures this directly, showing whether a lesion is still active or has responded to treatment.
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Know the cost before you commit
An itemised estimate, plus a check of which schemes you may qualify for.
When is PET-CT likely to be preferred over a bone scan?
- Your cancer is multiple myeloma — bone scans are often falsely negative because myeloma destroys bone rather than triggering repair.
- Your oncologist needs to assess whether current treatment is working, not just locate new lesions.
- Your cancer commonly causes lytic bone spread, such as kidney cancer or some thyroid cancers.
- Staging needs to include both soft tissue and bone in a single session.
- A previous bone scan finding is ambiguous and needs further characterisation to confirm active disease.
- Your oncologist needs current metabolic status before deciding whether to change treatment.
Is a bone scan good enough, or will it miss something?
For most cancers where bone spread is suspected, a bone scan is the guideline-recommended first investigation. NCCN and ESMO both list it as standard for initial staging of prostate cancer and in several breast cancer protocols — not a rationed or budget option.
The scan detects bone repair activity around a metastasis, which is reliable for the most common types of spread. Where it performs less well is in cancers that destroy bone directly without triggering much repair — multiple myeloma is the clearest example. In those situations, your oncologist will choose a different test.
Being offered a bone scan when you expected PET-CT is not a sign that resources are being held back. It almost always means the bone scan answers the specific clinical question being asked.
When does the extra cost of PET-CT justify itself?
PET-CT earns its higher cost when the bone scan cannot answer the question — most often when treatment response needs to be measured, or when the cancer type causes lytic spread that bone scans miss.
For most initial staging decisions, PET-CT does not change what the oncologist recommends over a bone scan. When it does change the decision, its cost is quickly justified against the alternative of continuing a treatment that is not working.
If you are uncertain why a particular scan was ordered, ask your oncologist directly: will a different scan change your treatment recommendation? If the answer is no, you have your answer.
PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad — across 4 partner centres in Banjara Hills, Punjagutta, Himayatnagar and Narayanaguda. Indicative price, as of September 2026.
Explore 30 more Specialised Tracers and How PET-CT Compares topics
PET-CT vs Other Scans
- Can an MRI Replace a PET-CT to Avoid Radiation?
- Choosing Between Scans: A Decision Guide by Question
- Combining PET-CT With MRI in the Same Week
- Diagnostic CT vs the CT Inside a PET-CT
- Do You Need Both a CT and a PET-CT?
- Follow-Up Scanning: Alternating PET With Other Tests
- PET-CT vs Biopsy: Which Actually Diagnoses Cancer?
- PET-CT vs Bone Scan for Bone Metastases
- PET-CT vs CT Scan: What Is the Difference?
- PET-CT vs MRI: Which Do You Need?
- PET-CT vs PET-MRI: Is the Newer Machine Better?
- PET-CT vs Tumour Markers for Follow-Up
- PET-CT vs Ultrasound and Mammography
- PET-CT vs Whole-Body MRI for Screening
- When Is a PET-CT Not the Right Test?
- Why Your Doctor Ordered PET-CT and Not a Cheaper Scan
Timing Around Treatment
- Baseline PET-CT Before Starting Treatment: Why It Matters
- Can a PET-CT Be Done During Active Chemotherapy?
- Emergency and Urgent PET-CT: When It Cannot Wait
- How Soon After a Previous PET Can You Have Another?
- Interim vs End-of-Treatment Scanning
- PET-CT After Growth Factor Injections
- PET-CT After Steroids: Does It Affect the Scan?
- PET-CT After a Biopsy: How Long to Wait
- PET-CT Before Surgery: What Surgeons Want to Know
- Scanning Too Early: Why It Wastes Money and Causes Panic
- When Should You Have a PET-CT After Chemotherapy?
- When Should You Have a PET-CT After Immunotherapy?
- When Should You Have a PET-CT After Radiotherapy?
- When Should You Have a PET-CT After Surgery?
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Frequently asked questions
Which scan is more accurate for bone metastases?
Neither is unconditionally more accurate — accuracy depends on your cancer type. For osteoblastic spread from prostate cancer, a bone scan is highly sensitive and is the NCCN-recommended first test. For multiple myeloma or cancers with lytic spread, PET-CT or MRI is more reliable because bone scans frequently miss bone-destroying disease. Your oncologist picks the scan most likely to be accurate for your specific cancer, not the most expensive or most recent one.
My oncologist ordered a bone scan, not PET-CT — are they cutting corners?
Almost certainly not. A bone scan is the standard investigation for most cancers where bone spread is suspected. For prostate cancer, NCCN and ESMO both list it as the appropriate first-line test. If you are concerned, ask your oncologist which clinical question the scan is answering and whether a different scan would change their plan. That is a reasonable question to ask, and the answer will usually explain the choice clearly.
Can I pay to upgrade to PET-CT privately even if my doctor recommended a bone scan?
You can, but it may not give you more useful information. If your cancer type is one where a bone scan is reliable, PET-CT is unlikely to change the clinical picture — and it carries a higher radiation dose and significantly higher cost. Ask first: if PET-CT would not change your oncologist's recommendation, it will not change your treatment. If it would change it, ask why it was not requested in the first place.
How long does each scan take?
A bone scan is a two-stage process: a radiotracer is injected, and you return two to four hours later for imaging that takes around 30 to 45 minutes. PET-CT requires fasting beforehand, then an hour's wait after the tracer injection before a scan of around 20 to 30 minutes. Plan the full day for either, and arrange transport — you should not drive immediately after either procedure.
Is it safe to have either scan during chemotherapy or immunotherapy?
Yes, both are generally safe alongside most cancer treatments. Tell the scanning team what you are receiving — some drugs affect how the tracer is absorbed or how images are interpreted. Your oncologist will also time the scan appropriately: a PET-CT done too soon after chemotherapy can give misleading results because the metabolic changes in cancer cells take time to appear after treatment.
What does it mean if my bone scan and PET-CT give different results?
Discordant results are common and do not mean one scan is wrong. A bone scan can remain positive after a metastasis has responded to treatment, because the bone repair response persists even after the cancer cells have been treated. PET-CT may show the same lesion as metabolically inactive — a more current picture of disease activity. Your oncologist will interpret both results in the context of your treatment history before drawing any conclusions.